Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Astellas to offer $981mm cash for CV Therapeutics; withdrawn

Executive Summary

Astellas Pharma has publicly disclosed an estimated $981mm cash bid to acquire CV Therapeutics after a year of attempting to discuss a possible transaction with the public US cardiovascular company. CV rejected the proposal, which was initially received in November 2008.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Includes Contract
    • Payment Includes Cash
    • Full Acquisition

Related Companies

UsernamePublicRestriction

Register